BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leroux S, Jacqz-Aigrain E, Biran V, Lopez E, Madeleneau D, Wallon C, Zana-Taïeb E, Virlouvet AL, Rioualen S, Zhao W. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates. Antimicrob Agents Chemother 2016;60:2039-42. [PMID: 26787690 DOI: 10.1128/AAC.02214-15] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tauzin M, Cohen R, Durrmeyer X, Dassieu G, Barre J, Caeymaex L. Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal. Front Pediatr 2019;7:188. [PMID: 31139607 DOI: 10.3389/fped.2019.00188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
2 Monteiro JF, Hahn SR, Gonçalves J, Fresco P. Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations. Pharmacol Res Perspect 2018;6:e00420. [PMID: 30156005 DOI: 10.1002/prp2.420] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
3 Euteneuer JC, Kamatkar S, Fukuda T, Vinks AA, Akinbi HT. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy. J Clin Pharmacol 2019;59:168-76. [PMID: 30204236 DOI: 10.1002/jcph.1315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
4 Gonzalez D, Rao GG, Bailey SC, Brouwer KLR, Cao Y, Crona DJ, Kashuba ADM, Lee CR, Morbitzer K, Patterson JH, Wiltshire T, Easter J, Savage SW, Powell JR. Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact. Clin Transl Sci 2017;10:443-54. [PMID: 28875519 DOI: 10.1111/cts.12490] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
5 Liang H, Zhang L, Guo X, Sun L. Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants. BMC Pediatr 2021;21:3. [PMID: 33397325 DOI: 10.1186/s12887-020-02482-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 van Donge T, Smits A, van den Anker J, Allegaert K. Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates. Int J Environ Res Public Health 2021;18:E662. [PMID: 33466764 DOI: 10.3390/ijerph18020662] [Reference Citation Analysis]
7 Mejías-Trueba M, Alonso-Moreno M, Herrera-Hidalgo L, Gil-Navarro MV. Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review. Antibiotics (Basel) 2021;10:347. [PMID: 33805874 DOI: 10.3390/antibiotics10040347] [Reference Citation Analysis]
8 Gijsen M, Vlasselaers D, Spriet I, Allegaert K. Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine. Antibiotics (Basel) 2021;10:1182. [PMID: 34680763 DOI: 10.3390/antibiotics10101182] [Reference Citation Analysis]
9 Alsultan A, Alghamdi WA, Alghamdi J, Alharbi AF, Aljutayli A, Albassam A, Almazroo O, Alqahtani S. Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia. Saudi Pharm J 2020;28:1217-27. [PMID: 33132716 DOI: 10.1016/j.jsps.2020.08.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Abdulla A, Edwina AE, Flint RB, Allegaert K, Wildschut ED, Koch BCP, de Hoog M. Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review. Front Pediatr 2021;9:624639. [PMID: 33708753 DOI: 10.3389/fped.2021.624639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]